mpa depot Search Results


medroxyprogesterone acetate  (European Directorate for the Quality of Medicines and HealthCare)
86
European Directorate for the Quality of Medicines and HealthCare medroxyprogesterone acetate
Chemical structures for <t>medroxyprogesterone</t> acetate (MPA) and its known impurities . A - 6-hydroxymedroxyprogesterone acetate (6β-hydroxy-6-methyl-3,20-dioxopregn-4-en-17-yl acetate); B – medroxyprogesterone (17-hydroxy-6α-methylpregn-4-ene-3,20-dione); C - 6α,17α-dimethyl-3,17-dioxo- d -homoandrost-4-en-17α-yl acetate; D - 6-epimedroxyprogesterone acetate (6β-methyl-3,20-dioxopregn-4-en-17-yl acetate); E - 6-methylenehydroxyprogesterone acetate (6-methylidene-3,20-dioxopregn-4-en-17-yl acetate); F - 4,5-dihydromedroxyprogesterone acetate (6α-methyl-3,20-dioxo-5β-pregn-17-yl acetate); G - megestrol acetate (6-methyl-3,20-dioxopregna-4,6-dien-17-yl acetate); H - hydroxyprogesterone acetate (3,20-dioxopregn-4-en-17-yl acetate); I - 17β-hydroxy-6α,17α-dimethyl- d -homoandrost-4-en-3,17-dione.
Medroxyprogesterone Acetate, supplied by European Directorate for the Quality of Medicines and HealthCare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/medroxyprogesterone acetate/product/European Directorate for the Quality of Medicines and HealthCare
Average 86 stars, based on 1 article reviews
medroxyprogesterone acetate - by Bioz Stars, 2026-04
86/100 stars
  Buy from Supplier
mpa depot (medrosterone)  (Gador SA)
90
Gador SA mpa depot (medrosterone)
Chemical structures for <t>medroxyprogesterone</t> acetate (MPA) and its known impurities . A - 6-hydroxymedroxyprogesterone acetate (6β-hydroxy-6-methyl-3,20-dioxopregn-4-en-17-yl acetate); B – medroxyprogesterone (17-hydroxy-6α-methylpregn-4-ene-3,20-dione); C - 6α,17α-dimethyl-3,17-dioxo- d -homoandrost-4-en-17α-yl acetate; D - 6-epimedroxyprogesterone acetate (6β-methyl-3,20-dioxopregn-4-en-17-yl acetate); E - 6-methylenehydroxyprogesterone acetate (6-methylidene-3,20-dioxopregn-4-en-17-yl acetate); F - 4,5-dihydromedroxyprogesterone acetate (6α-methyl-3,20-dioxo-5β-pregn-17-yl acetate); G - megestrol acetate (6-methyl-3,20-dioxopregna-4,6-dien-17-yl acetate); H - hydroxyprogesterone acetate (3,20-dioxopregn-4-en-17-yl acetate); I - 17β-hydroxy-6α,17α-dimethyl- d -homoandrost-4-en-3,17-dione.
Mpa Depot (Medrosterone), supplied by Gador SA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mpa depot (medrosterone)/product/Gador SA
Average 90 stars, based on 1 article reviews
mpa depot (medrosterone) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
depot-mpa  (Anwendung GmbH)
90
Anwendung GmbH depot-mpa
Chemical structures for <t>medroxyprogesterone</t> acetate (MPA) and its known impurities . A - 6-hydroxymedroxyprogesterone acetate (6β-hydroxy-6-methyl-3,20-dioxopregn-4-en-17-yl acetate); B – medroxyprogesterone (17-hydroxy-6α-methylpregn-4-ene-3,20-dione); C - 6α,17α-dimethyl-3,17-dioxo- d -homoandrost-4-en-17α-yl acetate; D - 6-epimedroxyprogesterone acetate (6β-methyl-3,20-dioxopregn-4-en-17-yl acetate); E - 6-methylenehydroxyprogesterone acetate (6-methylidene-3,20-dioxopregn-4-en-17-yl acetate); F - 4,5-dihydromedroxyprogesterone acetate (6α-methyl-3,20-dioxo-5β-pregn-17-yl acetate); G - megestrol acetate (6-methyl-3,20-dioxopregna-4,6-dien-17-yl acetate); H - hydroxyprogesterone acetate (3,20-dioxopregn-4-en-17-yl acetate); I - 17β-hydroxy-6α,17α-dimethyl- d -homoandrost-4-en-3,17-dione.
Depot Mpa, supplied by Anwendung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/depot-mpa/product/Anwendung GmbH
Average 90 stars, based on 1 article reviews
depot-mpa - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
depot-medroxyprogesteronacetat depot-mpa  (Anwendung GmbH)
90
Anwendung GmbH depot-medroxyprogesteronacetat depot-mpa
Chemical structures for <t>medroxyprogesterone</t> acetate (MPA) and its known impurities . A - 6-hydroxymedroxyprogesterone acetate (6β-hydroxy-6-methyl-3,20-dioxopregn-4-en-17-yl acetate); B – medroxyprogesterone (17-hydroxy-6α-methylpregn-4-ene-3,20-dione); C - 6α,17α-dimethyl-3,17-dioxo- d -homoandrost-4-en-17α-yl acetate; D - 6-epimedroxyprogesterone acetate (6β-methyl-3,20-dioxopregn-4-en-17-yl acetate); E - 6-methylenehydroxyprogesterone acetate (6-methylidene-3,20-dioxopregn-4-en-17-yl acetate); F - 4,5-dihydromedroxyprogesterone acetate (6α-methyl-3,20-dioxo-5β-pregn-17-yl acetate); G - megestrol acetate (6-methyl-3,20-dioxopregna-4,6-dien-17-yl acetate); H - hydroxyprogesterone acetate (3,20-dioxopregn-4-en-17-yl acetate); I - 17β-hydroxy-6α,17α-dimethyl- d -homoandrost-4-en-3,17-dione.
Depot Medroxyprogesteronacetat Depot Mpa, supplied by Anwendung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/depot-medroxyprogesteronacetat depot-mpa/product/Anwendung GmbH
Average 90 stars, based on 1 article reviews
depot-medroxyprogesteronacetat depot-mpa - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Chemical structures for medroxyprogesterone acetate (MPA) and its known impurities . A - 6-hydroxymedroxyprogesterone acetate (6β-hydroxy-6-methyl-3,20-dioxopregn-4-en-17-yl acetate); B – medroxyprogesterone (17-hydroxy-6α-methylpregn-4-ene-3,20-dione); C - 6α,17α-dimethyl-3,17-dioxo- d -homoandrost-4-en-17α-yl acetate; D - 6-epimedroxyprogesterone acetate (6β-methyl-3,20-dioxopregn-4-en-17-yl acetate); E - 6-methylenehydroxyprogesterone acetate (6-methylidene-3,20-dioxopregn-4-en-17-yl acetate); F - 4,5-dihydromedroxyprogesterone acetate (6α-methyl-3,20-dioxo-5β-pregn-17-yl acetate); G - megestrol acetate (6-methyl-3,20-dioxopregna-4,6-dien-17-yl acetate); H - hydroxyprogesterone acetate (3,20-dioxopregn-4-en-17-yl acetate); I - 17β-hydroxy-6α,17α-dimethyl- d -homoandrost-4-en-3,17-dione.

Journal: Journal of Pharmaceutical and Biomedical Analysis

Article Title: Forced degradation studies of medroxyprogesterone acetate injectable suspensions (150 mg/ml) with implementation of HPLC, mass spectrometry, and QSAR techniques

doi: 10.1016/j.jpba.2020.113352

Figure Lengend Snippet: Chemical structures for medroxyprogesterone acetate (MPA) and its known impurities . A - 6-hydroxymedroxyprogesterone acetate (6β-hydroxy-6-methyl-3,20-dioxopregn-4-en-17-yl acetate); B – medroxyprogesterone (17-hydroxy-6α-methylpregn-4-ene-3,20-dione); C - 6α,17α-dimethyl-3,17-dioxo- d -homoandrost-4-en-17α-yl acetate; D - 6-epimedroxyprogesterone acetate (6β-methyl-3,20-dioxopregn-4-en-17-yl acetate); E - 6-methylenehydroxyprogesterone acetate (6-methylidene-3,20-dioxopregn-4-en-17-yl acetate); F - 4,5-dihydromedroxyprogesterone acetate (6α-methyl-3,20-dioxo-5β-pregn-17-yl acetate); G - megestrol acetate (6-methyl-3,20-dioxopregna-4,6-dien-17-yl acetate); H - hydroxyprogesterone acetate (3,20-dioxopregn-4-en-17-yl acetate); I - 17β-hydroxy-6α,17α-dimethyl- d -homoandrost-4-en-3,17-dione.

Article Snippet: Medroxyprogesterone acetate for system suitability CRS (contains impurities A, B, C, D, E, G, I) and medroxyprogesterone acetate for peak identification (containing impurity F) were obtained from the European Pharmacopoeia through the European Directorate for the Quality of Medicines and Healthcare (EDQM, Strausbourg, France).

Techniques:

Example chromatogram for Reference Solution A with assignments for respective medroxyprogesterone impurities [ , , ], including relative retention times and +/- 2% RRT range observed for implemented chromatographic conditions.

Journal: Journal of Pharmaceutical and Biomedical Analysis

Article Title: Forced degradation studies of medroxyprogesterone acetate injectable suspensions (150 mg/ml) with implementation of HPLC, mass spectrometry, and QSAR techniques

doi: 10.1016/j.jpba.2020.113352

Figure Lengend Snippet: Example chromatogram for Reference Solution A with assignments for respective medroxyprogesterone impurities [ , , ], including relative retention times and +/- 2% RRT range observed for implemented chromatographic conditions.

Article Snippet: Medroxyprogesterone acetate for system suitability CRS (contains impurities A, B, C, D, E, G, I) and medroxyprogesterone acetate for peak identification (containing impurity F) were obtained from the European Pharmacopoeia through the European Directorate for the Quality of Medicines and Healthcare (EDQM, Strausbourg, France).

Techniques: